在选择的血管疾病中,蛋白质激酶C和内皮功能障碍
1Cardiothoracic Surgery Research Laboratory, Department of Medicine, Rhode Island Hospital, Brown University Health, Providence, RI, United States.
Frontiers in cardiovascular medicine
|September 10, 2025
概括
蛋白激酶C (PKC) 在血管内皮细胞中发挥关键作用,影响炎症和透性等过程. 功能失调的PKC活动有助于主要血管疾病,提供潜在的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 生物化学 生物化学
- 生理学 生理学 生理学
背景情况:
- 蛋白激酶调节重要的细胞过程,包括细胞亡,新陈代谢和增殖.
- 血管内皮细胞对于调节血管度, perfusion 和炎症至关重要.
- 蛋白激酶C (PKC) 已涉及血管生成,内皮透性和激活.
研究的目的:
- 审查PKC在血管内皮细胞中的作用.
- 检查与糖尿病,缺氧/缺血-再输液损伤和高血压相关的内皮功能障碍中的异常PKC活性.
主要方法:
- 对PKC结构,功能及其在内皮细胞中的作用的现有文献的综述.
- 讨论PKC参与内皮细胞循环,氧化应激,炎症和屏障完整性的作用.
主要成果:
- 异常的PKC活性是关键血管病理中的内皮功能障碍的驱动因素.
- PKC影响内皮细胞周期,氧化应激,炎症和屏障完整性.
结论:
- 了解内皮细胞-PKC病理生理学对于开发新型治疗策略至关重要.
- 向PKC可能会减轻与糖尿病,缺氧/缺血-再输损伤和高血压等血管疾病相关的发病率和死亡率.
相关概念视频
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
MAPK Signaling Cascades
8.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.0K
Protein Kinases and Phosphatases
15.0K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.0K
Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
Amplifying Signals via Enzymatic Cascade
17.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.5K


